Skip to main content
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
letter
. 1995 Aug;48(4):M219. doi: 10.1136/mp.48.4.m219-a

Central nervous system involvement by Mycoplasma pneumoniae

M Narita 1
PMCID: PMC407967  PMID: 16696011

Full text

PDF

Page M219

M219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kleemola M., Käyhty H. Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis. J Infect Dis. 1982 Aug;146(2):284–288. doi: 10.1093/infdis/146.2.284. [DOI] [PubMed] [Google Scholar]
  2. Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis. 1993 Aug;17 (Suppl 1):S52–S57. doi: 10.1093/clinids/17.Supplement_1.S52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Narita M., Matsuzono Y., Togashi T., Kajii N. DNA diagnosis of central nervous system infection by Mycoplasma pneumoniae. Pediatrics. 1992 Aug;90(2 Pt 1):250–253. [PubMed] [Google Scholar]
  4. Narita M., Matsuzono Y., Togashi T., Kajii N. DNA diagnosis of central nervous system infection by Mycoplasma pneumoniae. Pediatrics. 1992 Aug;90(2 Pt 1):250–253. [PubMed] [Google Scholar]
  5. Pönkä A. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis. 1980;12(3):175–184. doi: 10.3109/inf.1980.12.issue-3.04. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES